Speakers

Stefanie Urlinger

Chief Scientific Officer • Cimeio Therapeutics

Stefanie Urlinger is Chief Scientific Officer at Cimeio Therapeutics, where she heads Research and Discovery. Stefanie has over 20 years of experience in large molecule engineering and development and has led antibody discovery efforts as well as the development of antibody platform technologies in different organizations, including MorphoSys, iOmx Therapeutics and Ridgeline Discovery. Stefanie has authored many scientific articles and is an inventor on over 60 granted patents. Stefanie earned her PhD from the Max-Planck-Institute for Biochemistry in Germany.

Also speaking

Stuart Curbishley

Chief Manufacturing and Development Officer • Adthera Bio

Simon Hort

Team Leader Adaptive Production Control • Fraunhofer

Avencia Sanchez-Mejias

Co-Founder and CEO • Integra Therapeutics

Event Info

Image

Event Brochure

Take a look at the 2023 Event Brochure for Advanced Therapies Europe.
Image

Download the 2023 Speaker List

Download the 2023 Speaker List for Advanced Therapies Europe here.